NewsRoom Articles - Page 8 of 44

MondayApr 08, 2024 11:15 am

Diamond Lake Minerals Inc. (DLMI) Continues to Leverage Tokenization to Open New Opportunities for Investors Globally

DLMI, a multi-strategy operating company, is tapping into expanding digital securities and global blockchain industries by asserting itself as a trusted authority in the tokenization space In an interview with Proactive’s Stephen Gunnion, Brian J. Esposito, DLMI’s CEO, noted how tokenization is redefining investing by opening up global markets to real-world assets He reiterated his goal to build strong earnings, provide shareholder value with sustainable, healthy growth, and grow the DLMI brand Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company specializing in the development and support of digital assets and SEC-registered tokens, is looking to capitalize on the growing…

ThursdayApr 04, 2024 9:00 am

Diamond Lake Minerals Inc. (DLMI) Is Actively Involved in the Potentially Revolutionary ‘Next Generation for Markets’

Tokenization, the process of developing and issuing a digital asset representing a real-world asset, is gaining recognition, as BlackRock CEO Larry Fink states that it will be the “next generation for markets” Brian J. Esposito, the CEO of multi-strategy operating company Diamond Lake Minerals, shares Fink’s vision and regards tokenization as a game-changing concept for investors Esposito believes tokenized assets provide opportunities to people who would have never had a chance to directly own such assets or participate in offerings DLMI hopes to capture a significant market share by offering SEC-registered tokens, appealing to investors who might be reticent to…

MondayMar 25, 2024 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires Contract Research Organization to Perform Important GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human pilot study which will test a dissolvable DehydraTECH-GLP-1 oral dose formulation The announcement follows Lexaria’s WEIGHT-A24-1 animal study announcement examining diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and cannabidiol alone and in combination The move aligns with the company’s resolve to focus on their ability to enhance the delivery of GLP-1 diabetes and obesity drugs At the beginning of the year, Lexaria Bioscience (NASDAQ: LEXX), a global innovator for enhanced drug delivery platforms, announced its intention to double…

MondayMar 25, 2024 11:15 am

Diamond Lake Minerals Inc. (DLMI) Recognizes Tokenization As The Future of Financial Markets

Larry Fink, CEO of BlackRock, foresees a future where every financial asset is tokenized Tokenization promises a future where investing is more efficient, transparent, and accessible, ultimately reshaping the financial landscape Diamond Lake Minerals employs state-of-the-art technology to develop and support digital assets and SEC-registered security tokens – setting new industry standards for security and compliance The cryptocurrency frenzy may overshadow a quieter yet monumental revolution in finance: the tokenization of financial assets. This movement, powered by blockchain technology, aims to digitize and securely represent assets like stocks, bonds, and real estate, eliminating intermediaries and streamlining transactions. Diamond Lake Minerals (OTC:…

MondayMar 25, 2024 9:45 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Helps Lead the Electric Boating Revolution, Establishes Partnership with Key Distributor

Electric boats offer an impressive list of benefits for boating enthusiasts New partnership establishes exclusive distributorship agreement for south Florida, includes “milestone” order for VMAR’s Phantom Nautical Ventures Marine Group has ordered 50 units of VMAR’s Phantom, a boat constructed from fully recyclable materials The advantages of electric propulsion are spreading beyond the roads to the waterways. Boat enthusiasts see the importance of sustainability as they consider electric boats, but they are recognizing other perks as well. The swell of support for electric boats can be seen in many ways, including the recent news from Vision Marine Technologies (NASDAQ: VMAR), a…

ThursdayMar 21, 2024 12:00 pm

Diamond Lake Minerals Inc. (DLMI) Announces Investment in Avrio Worldwide PBC Amidst Avrio’s Acquisition of HUMBL and SocialTrader

Diamond Lake Minerals purchased a 24% stake in Avrio Worldwide PBC in a strategic investment opportunity Avrio has partnered with HUMBL Financial to acquire the HUMBL Financial brand, products, and services Avrio also announced a 1:10 share exchange agreement, resulting in a bi-directional common stock acquisition between the company and SocialTrader.AI SocialTrader will deploy Avrio's digital financial market infrastructure to access public, private, and digital markets across multiple asset classes Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company on a path to emerging as a pioneering force in the development of digital assets and SEC-registered security tokens, recently announced…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

WednesdayMar 20, 2024 9:00 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils New E-Boat Model, Names New CFO in Preparation for Industry Growth

The global electric boats market is forecast to more than double in size, increasing from $3.3 billion in 2023 to $7.7 billion by 2030 Vision Marine’s unveiling of its newest e-boat offering, the Phantom, couldn’t have come at more opportune time The company’s new chief financial officer brings invaluable expertise and insight in manufacturing, production and delivery As the electric boat sector is projected to double in value in the next few years, companies operating in the industry are positioning themselves to meet — and even exceed — the expectations this growth could create. For example, Vision Marine Technologies (NASDAQ:…

MondayMar 18, 2024 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

CNS Pharmaceuticals recently appointed Amy Mahery, a biotech commercialization leader, to its Board of Directors Ms. Mahery brings over 20 years’ experience, having worked with small and large companies, and has held diverse commercial leadership roles in the U.S. and globally The company believes Ms. Mahery’s guidance, insight, and vast pharma industry network will indeed be invaluable as the company advances Berubicin, its flagship drug candidate, toward completion of its global potentially pivotal clinical trial and potential regulatory approval The company recently completed the enrollment of patients in its potentially pivotal global clinical trial Ms. Mahery believes Berubicin represents an…

MondayMar 18, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria, a global innovator in drug delivery platforms, recently received FDA clearance for its HYPER-H23-1 clinical study John Docherty, President of Lexaria, has regarded this milestone as a demonstration of its patented DehydraTECH(TM) technology’s overall viability, particularly in the potential treatment of hypertension With HYPER-H23-1, Lexaria looks to build on the success of its previous human clinical studies, whose results have been overwhelmingly positive This marks a considerable milestone even as the company looks to double down on GLP-1 studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced that the…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000